JPRN-jRCT2080225019已完成3 期
Please refer to ClinicalTrials.gov : NCT03070119.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 138
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Please refer to ClinicalTrials.gov : NCT03070119.
排除标准
- •Please refer to ClinicalTrials.gov : NCT03070119.
研究者
相似试验
终止
2 期
Please refer to ClinicalTrials.gov : NCT03954041Brain ContusionJPRN-jRCT2080224849Biogen Japan Ltd.160
终止
3 期
Please refer to ClinicalTrials.gov : NCT02864953.JPRN-jRCT2080224029Biogen Japan Ltd.768
已完成
3 期
Please refer to ClinicalTrials.gov : NCT04241068.Alzheimer's diseaseJPRN-jRCT2080225185Biogen Japan Ltd.2,400
招募中
2 期
Effectiveness of Perilla oil with Mild to Moderate of Dementia PatientDevelopment of the medical and society led to population in the world are long life which rate of height birth in last time relate with be in move to aged elderly. Campaign for control the birth rateDementia,alzheimer's disease,Perilla frutescens (L.) Britton,Omaga3,Clinical Trial,Randomize Control Trial,Cognitive function,MOCATCTR20150914001Agricultural Research Development Agency (Public Organization)234
进行中（未招募）
1 期
Phase I trial, CRO code: 21-013The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended.ISRCTN10271810Beckley Psytech Ltd.48